The study began with a deceptively simple question: which genes, when silenced in the fat body, change the growth of organs elsewhere in the animal? Answering it required a screening system that could measure growth in living larvae rather than relying on laborious dissection and imaging. The team engineered a reporter line, dubbed GQ, in which the fat body drives genetic knockdowns while the growth response is read out in peripheral tissues, specifically the imaginal discs, the larval structures that will eventually form adult wings, legs, and eyes. These discs carry a firefly luciferase reporter whose activity scales with tissue growth, while a Renilla luciferase reporter provides an internal reference. By homogenizing individual larvae at a standardized developmental time point, 115 hours after egg deposition, and running dual luciferase assays, the researchers could quantify the growth consequences of each fat-body-specific gene knockdown in a single, rapid measurement.

Using RNA interference lines from the Vienna Drosophila Resource Center, the team systematically knocked down secreted and secretory-pathway genes in the fat body and scored the resulting effects on imaginal disc growth. The primary screen flagged dozens of candidate genes, and a rigorous secondary screen retested each hit with multiple independent RNAi transgenes, including lines from the Bloomington stock center and the National Institute of Genetics in Japan. Only candidates whose effects could be reproduced with independent reagents were considered genuine. Out of the retested genes, 32 were confirmed with high confidence, three showed moderate effects, and 13 failed validation, a sobering reminder of why independent confirmation is essential in genetic screens. Among the confirmed hits, one protein stood out for both the strength of its effect and the elegance of its mechanism: SPARC, short for Secreted Protein Acidic and Rich in Cysteine, also known as BM-40.

SPARC is a matricellular protein, meaning it is secreted into the extracellular environment but does not serve as a structural component of the matrix itself. Instead, matricellular proteins modulate cell-matrix interactions and cell signaling. In mammals, SPARC has been implicated in tissue remodeling, wound repair, fibrosis, and cancer biology, but its role as an endocrine growth regulator had not been established. The new work shows that when SPARC production is reduced in the larval fat body, the entire animal grows less. Adult flies with fat-body SPARC knockdown emerge smaller, with reduced body weight and smaller wings, effects that were quantified by measuring adult dry weight and wing area across multiple independent experiments and temperatures. The consistency of the size reduction across different driver lines and RNAi constructs pointed to a genuine developmental function rather than a technical artifact.

The critical question was how a protein secreted from the fat body could slow the growth of tissues it never touches directly. The answer lies in a small cluster of neurosecretory cells in the larval brain called the insulin-producing cells, or IPCs. These cells are the functional counterparts of human pancreatic beta cells: they release Drosophila insulin-like peptides, particularly Ilp2, into the circulation, and circulating insulin activates the insulin signaling pathway in target tissues, driving cell growth and proliferation. When the researchers examined the IPCs of larvae in which the fat body had been depleted of SPARC, they found that Ilp2 accumulated inside the cells instead of being released. In other words, the peptide was being made but retained, a classic secretory defect. Fat-body SPARC, it appears, is required for the proper endocrine release of insulin from the brain, acting as an incretin-like signal that promotes insulin secretion in response to nutritional conditions.

Several control experiments strengthened this interpretation. A short, one-day depletion of SPARC did not grossly disrupt larval feeding behavior or fat body integrity, arguing against the possibility that the growth defects were secondary to starvation or tissue damage. Larvae with SPARC knockdown still ingested food normally, as shown by feeding assays with dye-labeled yeast paste, and their fat body architecture, visualized with nuclear and membrane stains, remained intact. The team also showed that SPARC is indeed secreted into the hemolymph, the insect circulatory fluid, where it can be detected by western blotting, and that its expression responds to nutritional state, with starvation reducing SPARC mRNA levels in the fat body. These observations fit a model in which the fat body, upon sensing adequate nutrition, secretes SPARC into the circulation, and SPARC in turn stimulates the IPCs to release Ilp2, thereby licensing systemic growth.

Perhaps the most striking result of the study is its evolutionary punchline. When the researchers supplied synthetic human SPARC to fly larvae lacking their own SPARC, the human protein could substitute for the fly version, restoring insulin release and growth. This cross-species rescue demonstrates that the biochemical function of SPARC in this signaling axis has been conserved over hundreds of millions of years of evolution separating insects and vertebrates. It also raises an obvious and tantalizing question for mammalian biology: could SPARC play a comparable role in human insulin regulation? Mammalian incretins, such as GLP-1, are gut-derived hormones that potentiate insulin secretion from pancreatic beta cells, and they form the basis of a major class of diabetes drugs. A fat-derived, SPARC-dependent pathway that promotes insulin release would represent a fundamentally new branch of this regulatory logic, though the authors are careful to frame the human implications as a hypothesis for future work rather than a demonstrated mechanism.

The technical achievement behind the discovery deserves attention in its own right. Traditional genetic screens for growth regulators require laborious measurements of organ size, often by microscopy, which limits throughput and introduces variability. By coupling a tissue-specific knockdown system to a luciferase-based growth readout, the Würzburg team created a pipeline in which a single larva yields a quantitative growth measurement in a plate reader. The dual-reporter design, with firefly luciferase reporting imaginal disc growth and Renilla luciferase normalizing for larval size and handling differences, allowed hundreds of genotypes to be assayed individually. The supplementary data accompanying the paper document the full trajectory of the screen, from the primary results across the tested lines to the validation tables listing every independent transgene and its effect, providing an unusually transparent record of how the conclusions were reached.

Beyond SPARC itself, the study delivers a conceptual message about how growth is coordinated across an animal. The fat body is not merely a passive energy depot; it is an endocrine gland whose secreted products reach into the brain and tune the output of the insulin-producing cells. This architecture mirrors the inter-organ communication circuits of mammals, in which the liver, adipose tissue, gut, and pancreas exchange hormonal signals to match growth and metabolism to nutrient availability. Disruptions in such circuits are central to metabolic disease, and understanding their components in a genetically tractable organism like Drosophila provides a framework for dissecting the corresponding human pathways. The identification of SPARC as an incretin-like, insulin-promoting signal adds a new name to the roster of conserved growth regulators and suggests that the extracellular matrix, long viewed as structural scaffolding, participates directly in endocrine control.

Future experiments will need to determine exactly how SPARC acts on the IPCs, whether it binds a specific receptor on these cells, modulates their secretory machinery, or acts through intermediate signals in the hemolymph. It will also be important to establish whether the SPARC-dependent pathway responds to specific nutrients and how it integrates with other known fat-body-derived signals that influence insulin release and growth. For now, the study stands as a vivid example of modern genetics at work: a systematic in vivo screen, a rigorous validation pipeline, and a mechanistic story that connects a secreted matrix protein in the fat body to insulin granules in the brain and, ultimately, to the size of the adult fly. In doing so, it transforms our picture of how a growing animal counts its calories and converts them into body mass, and it plants a flag for SPARC in a territory where few would have thought to look.

Subject of Research: Fat body-derived SPARC signaling in the regulation of insulin release and systemic larval growth in Drosophila

Article Title: Fat body secreted SPARC promotes Ilp2 release and systemic growth in Drosophila larvae

Article References: Fat body secreted SPARC promotes Ilp2 release and systemic growth in Drosophila larvae. (n.d.). https://doi.org/10.1186/s12915-026-02761-x

Image Credits: AI Generated

DOI: 10.1186/s12915-026-02761-x

Keywords: Drosophila, SPARC, insulin signaling, fat body, Ilp2, incretin, larval growth, inter-organ communication, genetic screen, nutrient signaling, insulin-producing cells, BMC Biology

For decades, the scientific consensus maintained that RNA, as a crucial intermediate in the central dogma of biology, typically exerts its functions within the confines of the cell in which it was transcribed. While extracellular vesicles and circulating nucleic acids had hinted at a degree of intercellular RNA trafficking, definitive evidence for direct RNA transfer between distant organs remained elusive. The current study pierces this veil by demonstrating that specific RNA species synthesized in the liver appear subsequently in the kidney, suggesting an inter-organ RNA exchange paradigm previously unappreciated.

Central to this discovery is the application of the SLAMseq methodology, which stands for “thiol(SH)-linked alkylation for the metabolic sequencing of RNA.” This technique leverages chemical labeling to track newly synthesized RNA molecules with exquisite temporal resolution. By metabolically labeling RNA in the liver and sequencing it from downstream tissues, the researchers could definitively identify RNA molecules originating from hepatic cells that later localized in the kidney, proving a directional RNA transfer mechanism in vivo.

The significance of this technique cannot be overstated. Previous methods to study RNA trafficking often relied on indirect markers or were confounded by the complexity of in vivo systems. SLAMseq allowed for a direct and time-stamped capture of nascent RNA molecules, differentiating them from resident transcripts and enabling a dynamic view of RNA distribution across tissues. This advancement marks a milestone in RNA biology, turning a previously abstract concept into tangible, measurable processes.

Delving deeper into the liver-to-kidney RNA transfer, the researchers observed that not all RNA species were equally transported. Certain messenger RNAs (mRNAs), microRNAs (miRNAs), and long non-coding RNAs (lncRNAs) were preferentially transferred, hinting at a selective mechanism governing RNA export and import between these organs. This selectivity implies functional roles for the transferred RNAs in modulating gene expression and cellular activity in recipient kidney tissues.

The physiological implications of such RNA transfer are profound. The liver is a metabolic powerhouse, regulating lipid metabolism, detoxification, and protein synthesis, while the kidney plays a critical role in filtration and homeostasis. The potential for the liver to communicate molecular instructions via RNA to the kidney suggests a previously unrecognized layer of regulation that could fine-tune renal function in response to systemic metabolic states or stress signals.

Intriguingly, the study also pointed to the involvement of extracellular vesicles, small membrane-bound particles known to mediate intercellular cargo shipment, in facilitating RNA transfer. The researchers hypothesize that these vesicles act as RNA shuttles, protecting fragile RNA cargo from degradation in the circulation and delivering messages intact to distant cell populations. This mechanism aligns with emerging data on extracellular vesicles as central players in intercellular communication.

Moreover, this inter-organ RNA transfer could have critical implications for disease pathogenesis and progression. Aberrant RNA trafficking might contribute to pathological signaling in chronic kidney disease, liver fibrosis, or systemic inflammatory conditions. Understanding the molecular determinants that govern RNA loading into vesicles and reception by recipient cells could reveal therapeutic targets to interrupt maladaptive molecular dialogues between organs.

Technological advancements like SLAMseq are key to unlocking these biological mysteries, providing tools not only for descriptive studies but also for dissecting mechanistic pathways. Future research employing this method may explore whether similar RNA transfer events occur between other organ pairs, such as heart and lung or brain and liver, thus broadening the impact of these findings into systemic physiology and pathology.

The researchers caution, however, that while evidence for RNA transfer is compelling, understanding the functional consequences remains an open challenge. Are these RNAs translated into proteins in recipient cells? Do they modulate gene expression epigenetically? Or are they merely molecular relics without significant biological activity? The answers to these questions will set the stage for a new research frontier.

In addition to clarifying functional outcomes, deciphering the molecular signals governing the packaging of specific RNAs for export and recognition mechanisms in target tissues will be critical. This demands interdisciplinary approaches combining molecular biology, bioinformatics, and systems biology to map RNA trajectories and interactions comprehensively.

The discovery also sparks interest in translational applications. Can this natural RNA transfer pathway be harnessed or mimicked to deliver therapeutic RNA payloads to targeted organs? If so, it could revolutionize RNA-based therapeutics by enabling systemic, organ-specific delivery without invasiveness or systemic toxicity.

Notably, this study raises foundational questions about the stability and lifespan of extracellular RNAs in the bloodstream, systemic biodistribution, and cellular uptake mechanisms. Understanding these aspects will inform both basic science and clinical strategies targeting RNA transport and communication.

The insights gleaned also challenge the dogma that organs operate in isolation molecularly, underscoring the complex, interconnected nature of organismal biology. RNA-based signaling pathways may represent a critical but underappreciated axis of physiological regulation beyond classical hormones and metabolites.

Finally, this research underscores the importance of technological innovation in revealing hidden biological processes. As methodologies like SLAMseq become more sophisticated and widespread, they will undoubtedly continue to unveil assumptions and dogmas in biology, imparting new perspectives on how life orchestrates its multifaceted molecular symphony across cellular and organ systems.

This pioneering work thus not only documents RNA transfer from liver to kidney but also opens a portal to a richer understanding of molecular communication in multicellular organisms. It marks a step forward in molecular biology, promising to shape future research, diagnostics, and therapeutics in the years to come.

Subject of Research: Inter-organ transfer of RNA molecules in mice, focusing on RNA movement from liver to kidney

Article Title: SLAMseq reveals potential transfer of RNA from liver to kidney in the mouse

Article References:
Hunter, R.W., Sun, J., Palmer, T. et al. SLAMseq reveals potential transfer of RNA from liver to kidney in the mouse. Nat Commun 16, 7413 (2025). https://doi.org/10.1038/s41467-025-62688-9

Image Credits: AI Generated